TokenPost·

Purple Biotech Posts $0.51 Third-Quarter GAAP Loss Per Share

Your call?

The company held $5.1 million in cash, cash equivalents and short-term deposits as of Sept. 30, 2026, with a projected runway through late 2027.

Share

More news